Damora Therapeutics (DMRA) Prepaid Assets (2019 - 2026)
Damora Therapeutics posted quarterly Prepaid Assets of $2.5 million for Q1 2026, up 507.51% year-on-year from $413000.0 in Q1 2025, and up 334.84% on a QoQ basis from $577000.0 in Q4 2025.
Damora Therapeutics (DMRA) has 8 years of Prepaid Assets data on file, last reported at $2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 507.51% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 507.51% YoY), and the FY2025 full-year result was $577000.0, down 2.2% from the prior year.
- Prepaid Assets for Q1 2026 stood at $2.5 million, up from $577000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.9 million in Q1 2023 and bottomed at $52000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $577000.0 (2025), against an average of $1.3 million.
- The widest annual swing landed in 2023, when Prepaid Assets surged 1446.22%; it then sank 96.91% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $52000.0 in 2022, then soared by 1388.46% to $774000.0 in 2023, then decreased by 23.77% to $590000.0 in 2024, then fell by 2.2% to $577000.0 in 2025, then surged by 334.84% to $2.5 million in 2026.
- The last three Prepaid Assets figures came in at $2.5 million (Q1 2026), $577000.0 (Q4 2025), and $56000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Damora Therapeutics | 853.36 Mn | 650.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.51 Mn |
| Dec 31, 2025 | 577,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 232,000.00 |
| Mar 31, 2025 | 413,000.00 |
| Dec 31, 2024 | 590,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 189,000.00 |
| Dec 31, 2023 | 774,000.00 |
| Sep 30, 2023 | 2.88 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Mar 31, 2023 | 3.88 Mn |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 214,000.00 |
| Jun 30, 2022 | 3.18 Mn |
| Mar 31, 2022 | 251,000.00 |
| Dec 31, 2021 | 334,000.00 |
| Sep 30, 2021 | 4.86 Mn |
| Jun 30, 2021 | 665,000.00 |
| Mar 31, 2021 | 6.57 Mn |
| Dec 31, 2020 | 242,000.00 |
| Sep 30, 2020 | 5.34 Mn |
| Dec 31, 2019 | 5.12 Mn |